CVE-2023-7171

Public Exploit
Novel-Plus Friendly Link FriendLinkController.java cross site scripting

Description

A vulnerability was found in Novel-Plus up to 4.2.0. It has been declared as problematic. Affected by this vulnerability is an unknown functionality of the file novel-admin/src/main/java/com/java2nb/novel/controller/FriendLinkController.java of the component Friendly Link Handler. The manipulation leads to cross site scripting. The attack can be launched remotely. The exploit has been disclosed to the public and may be used. The patch is named d6093d8182362422370d7eaf6c53afde9ee45215. It is recommended to apply a patch to fix this issue. The associated identifier of this vulnerability is VDB-249307.

Category

2.4
CVSS
Severity: Low
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.10%
Third-Party Advisory vuldb.com Third-Party Advisory vuldb.com
Affected: n/a Novel-Plus
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2023-7171?
CVE-2023-7171 has been scored as a low severity vulnerability.
How to fix CVE-2023-7171?
To fix CVE-2023-7171, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-7171 being actively exploited in the wild?
It is possible that CVE-2023-7171 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-7171?
CVE-2023-7171 affects n/a Novel-Plus.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.